(4R,7S,10S,13S,16S,19R)-N-((S)-1-amino-1-oxopropan-2-yl)-16-(2-amino-2-oxoethyl)-19-((S)-2,6-diaminohexanamido)-7,13-bis((R)-1-hydroxyethyl)-10-methyl-6,9,12,15,18-pentaoxo-1,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,22-icosahydrobenzo[v][1,20,4,7,10,13,16]dithiapentaazacyclotetracosine-4-carboxamide

ID: ALA2012073

Chembl Id: CHEMBL2012073

PubChem CID: 70683172

Max Phase: Preclinical

Molecular Formula: C38H61N11O11S2

Molecular Weight: 912.11

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H](NC(=O)[C@@H]1CSCc2ccccc2CSC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(N)=O

Standard InChI:  InChI=1S/C38H61N11O11S2/c1-18(31(42)53)43-35(57)26-16-61-14-22-9-5-6-10-23(22)15-62-17-27(46-33(55)24(40)11-7-8-12-39)36(58)45-25(13-28(41)52)34(56)49-29(20(3)50)37(59)44-19(2)32(54)48-30(21(4)51)38(60)47-26/h5-6,9-10,18-21,24-27,29-30,50-51H,7-8,11-17,39-40H2,1-4H3,(H2,41,52)(H2,42,53)(H,43,57)(H,44,59)(H,45,58)(H,46,55)(H,47,60)(H,48,54)(H,49,56)/t18-,19-,20+,21+,24-,25-,26-,27-,29-,30-/m0/s1

Standard InChI Key:  HALXZDDMDOPDDG-HVPOVZDUSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 912.11Molecular Weight (Monoisotopic): 911.3993AlogP: -4.82#Rotatable Bonds: 13
Polar Surface Area: 382.38Molecular Species: BASEHBA: 15HBD: 13
#RO5 Violations: 3HBA (Lipinski): 22HBD (Lipinski): 17#RO5 Violations (Lipinski): 3
CX Acidic pKa: 8.14CX Basic pKa: 25.66CX LogP: -6.10CX LogD: -9.25
Aromatic Rings: 1Heavy Atoms: 62QED Weighted: 0.08Np Likeness Score: 0.70

References

1. Kowalczyk R, Harris PW, Brimble MA, Callon KE, Watson M, Cornish J..  (2012)  Synthesis and evaluation of disulfide bond mimetics of amylin-(1-8) as agents to treat osteoporosis.,  20  (8): [PMID:22398258] [10.1016/j.bmc.2012.02.030]

Source